FluoSphera

Drug Discovery without animals

Based based in Geneva, Geneva, CH, FluoSphera works in industrial research tools, founded in 2021.

Profile

To successfully develop drugs, we need to precisely predict candidate drug metabolization, efficacy, and safety before clinical trials. FluoSphera integrates these three aspects with a systemic approach to better predict the effects of drugs before they reach the patient, thus reducing drug development failure. FluoSphera provides a more predictive alternative to animal experimentation using only human-derived tissues.

Its activity falls under industrial research tools; the profile below is assembled from public directory data.

The company is recorded as being based in Geneva, Geneva, CH.

Directory data places it at the SOSV portfolio company stage.

The company reports a headcount in the 2-10 range.

It has disclosed roughly $1M in funding.

Website: fluosphera.com